AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER

AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER

Show other versions (1)

<p><strong>Aim.</strong> To study the clinical forms of atrial fibrillation (AF), cardiovascular risk factors and comorbidities in these patients; to perform monitoring of complications and mortality in AF; to assess the quality of diagnosis and treatment of AF in real outpatient p...

Full description

Bibliographic Details
Main Authors:	V. V. Yakusevich, E. M. Pozdnyakova, Vl. .V. Yakusevich, V. A. Simonov, S. Yu. Martsevich, M. M. Loukianov, A. V. Zagrebelnyy, S. A. Boytsov
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2015-09-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	фибрилляция предсердий амбулаторная практика мониторинг событий
Online Access:	http://www.rpcardio.ru/jour/article/view/120

Similar Items

AN OUTPATIENT WITH ATRIAL FIBRILLATION: KEY FEATURES. THE FIRST DATA OF REKVAZA FP - YAROSLAVL REGISTER
by: V. V. Yakusevich, et al.
Published: (2015-09-01)

UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION
by: E. A. Protasova, et al.
Published: (2015-12-01)

DIAGNOSTICS, TREATMENT, ASSOCIATED CARDIOVASCULAR AND CONCOMITANT NON-CARDIAC DISEASES IN PATIENTS WITH DIAGNOSIS OF “ATRIAL FIBRILLATION” IN REAL OUTPATIENT PRACTICE (ACCORDING TO DATA OF REGISTRY OF CARDIOVASCULAR DISEASES, RECVASA)
by: M. M. Loukianov, et al.
Published: (2015-09-01)

Clinical significance of TNF-a assessment as inflammation marker in paroxysmal atrial fibrillation
by: E M Esedov, et al.
Published: (2014-12-01)

PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN ATRIAL FIBRILLATION - RAT POISON OR NEW ORAL ANTICOAGULANTS: DO WE HAVE A CHOICE, AND SHOULD WE BE AFRAID TO MAKE IT? FIRST CLINICAL EXPERIENCE WITH RIVAROXABAN IN NIZHNY NOVGOROD
by: L. Y. Koroleva, et al.
Published: (2015-09-01)

STROKE AS A RISK FACTOR IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE KRAF HOSPITAL REGISTER
by: Alexander Aleksandrovich Tuchkov, et al.
Published: (2019-07-01)

ATRIAL FIBROSIS IS A MORPHOLOGICAL BASIS OF ATRIAL FIBRILLATION
by: O. M. Drapkina, et al.
Published: (2015-09-01)

МЕТОД ОЦЕНКИ СОЦИАЛЬНОЙ КОМПЛАЕНТНОСТИ КАК ФОРМЫ СОЦИАЛЬНОЙ ОТВЕТСТВЕННОСТИ ПАЦИЕНТА
by: S. L. Boiko, et al.
Published: (2021-05-01)

ПАТОГЕНЕЗ, ПРОФИЛАКТИКА И ЛЕЧЕНИЕ ФИБРИЛЛЯЦИИ ПРЕДСЕРДИЙ ПОСЛЕ КАРДИОХИРУРГИЧЕСКИХ ВМЕШАТЕЛЬСТВ
by: статья Редакционная
Published: (2015-10-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY DURING CATHETER ABLATION TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION
by: E. A. Belikov, et al.
Published: (2015-09-01)

CHANGE OF LOCAL MYOCARDIAL CONTRACTILITY DUE TO SELECTION OF DIFFERENT ARRHYTHMIA TREATMENT STRATEGIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND PAROXYSMAL ATRIAL FIBRILLATION
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: NEW DATA AND NEW HORIZONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)

THE ASSESSMENT OF COMPLIANCE TO THE USE OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION ACCORDING TO THE PROFILE REGISTER
by: S. Y. Martsevich, et al.
Published: (2015-09-01)

Adherence to drug therapy in patients with atrial fibrillation
by: М A Kachkovskiy, et al.
Published: (2010-12-01)

HOW TO USE DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION
by: S. V. Moiseev
Published: (2015-12-01)

CHRONIC KIDNEY DISEASE AND CARDIOVASCULAR DISEASES: FOCUS ON ATRIAL FIBRILLATION
by: V. N. Shishkova
Published: (2015-09-01)

СРАВНЕНИЕ РЕЗУЛЬТАТОВ КОНКОМИТАНТНОЙ ПРОЦЕДУРЫ MAZE III И РАДИОЧАСТОТНОЙ АБЛАЦИИ ПРЕДСЕРДИЙ У ПАЦИЕНТОВ С КЛАПАННЫМИ ПОРОКАМИ СЕРДЦА
by: S. I. Zheleznev, et al.
Published: (2015-10-01)

The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design
by: S. N. Tereshchenko, et al.
Published: (2015-12-01)

ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: E. I. Leonova, et al.
Published: (2015-09-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY
by: M. Yu. Gilyarov
Published: (2015-12-01)

ВЛИЯНИЕ РАЗЛИЧНЫХ МОДИФИКАЦИЙ ПРОЦЕДУРЫ MAZE НА ГОРМОНАЛЬНУЮ ФУНКЦИЮ ПРЕДСЕРДИЙ И УРОВЕНЬ КАРДИОСПЕ-ЦИФИЧЕСКИХ МАРКЕРОВ ПОВРЕЖДЕНИЯ
by: S. I. Zheleznev, et al.
Published: (2018-06-01)

Длительное применение апиксабана у 91-летней пациентки с фибрилляцией предсердий, имеющей высокие риски тромбоэмболических и геморрагических осложнений
Published: (2016-12-01)

Catheter versus surgical ablation of atrial fibrillation after failed initial pulmonary vein isolation
by: Д. А. Елесин, et al.
Published: (2015-10-01)

ANTICOAGULATION IN ATRIAL FIBRILLATION PATIENTS AFTER CARDIOEMBOLIC STROKE: EVALUATION OF TREATMENT ADHERENCE IN REAL PRACTICE (Cohort study “APOLLON”)
by: I. A. Zolotovskaya, et al.
Published: (2017-08-01)

Short-term outcomes of surgical atrial ablation and septal myectomy
by: A. S. Zalesov, et al.
Published: (2021-09-01)

Clinical and electrophysiological predictors of radiofrequency ablation efficacy in patients with atrial fibrillation
by: S P Leschinskiy, et al.
Published: (2016-12-01)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01)

SECONDARY PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: THE CLINICIANS’ VIEWPOINT
by: E. A. Drozdova
Published: (2015-09-01)

Comparison of biatrial and left atrial radiofrequency ablation in patients with heart valves diseases
by: А. В. Богачев-прокофьев, et al.
Published: (2015-10-01)

IMPACT OF ATRIAL FIBRILLATION ON THE NEAR AND LONG-TERM PROGNOSIS OF LIFE AFTER ACUTE MYOCARDIAL INFARCTION. THE DATA OF THE LIS-1 STUDY (LYUBERTSY MORTALITY STUDY OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION)
by: S. Yu. Martsevich, et al.
Published: (2015-09-01)

Preventive AF ablation in patients with mitral valve lesion and left atrium enlargement: 3-month follow-up results
by: A. V. Bogachev-Prokophiev, et al.
Published: (2017-07-01)

ROBOTIC CATHETER ABLATION OF PERSISTENT ATRIAL FIBRILLATION (RANDOMIZED TRIAL RESULTS)
by: M. A. Naymushin, et al.
Published: (2017-12-01)

RISK OF THROMBOEMBOLIC COMPLICATIONS AND ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT AND RECURRENT ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: I. V. Grajfer, et al.
Published: (2015-12-01)

Clinical effectiveness of catheter treatment for atrial fibrillation depending on the dynamics of histological changes in the myocardium
by: A. E. Shelemehov, et al.
Published: (2020-09-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE
by: L. E. Kuvshinova, et al.
Published: (2015-09-01)

Efficiency of different techniques of ablation of longstanding persistent atrial fibrillation during coronary bypass surgery
by: А. М. Чернявский, et al.
Published: (2016-01-01)

Modulation of sympathetic nervous system by means of renal denervation for treatment of atrial fibrillation
by: А. Б. Романов, et al.
Published: (2015-10-01)

Occlusion of left atrial appendage in patients with atrial fibrillation
by: О. Н. Ганеева
Published: (2015-10-01)